GOSHEN CANCER CENTER OUTPATIENT PHARMACY - 200 High Park Ave, Goshen, IN

Great news! GOSHEN CANCER CENTER OUTPATIENT PHARMACY will accept the RxLess Assurance Plan. Just show the Assurance Plan discount to the pharmacist when picking up your medication.

The Goshen Cancer Center Outpatient Pharmacy, located at 200 High Park Ave in Goshen, IN 46526, is an essential component of the Goshen Cancer Center, specializing in providing medications and supportive care to oncology patients. The pharmacy offers a range of services tailored to meet the unique needs of cancer patients, from dispensing chemotherapy drugs to providing counseling on medication management and potential side effects.

One of the key features of the Goshen Cancer Center Outpatient Pharmacy is its dedicated team of pharmacists and pharmacy technicians who are experienced in oncology care. They work closely with the oncologists and other healthcare providers to ensure that patients receive personalized and comprehensive pharmaceutical care. The pharmacy's approach to customer care is centered around compassion, empathy, and clear communication, aimed at supporting patients and their families throughout their cancer treatment journey.

For those approaching the Goshen Cancer Center Outpatient Pharmacy from the north, south, east, and west, here are the turn-by-turn directions:
- From the north: Take US-33 S, turn left onto E Lincoln Ave, and then turn right onto High Park Ave.
- From the south: Drive north on US-33 N, turn right onto E Pike St, turn left onto S 3rd St, and then turn right onto High Park Ave.
- From the east: Head west on US-33 W, turn right onto IN-15 N, turn left onto E Madison St, and then turn left onto High Park Ave.
- From the west: Drive east on US-33 E, turn left onto Greene Rd, turn right onto E Madison St, and then turn left onto High Park Ave.

Overall, the Goshen Cancer Center Outpatient Pharmacy provides a vital service to cancer patients in the community, offering not just medications but also support and guidance to enhance patient outcomes and improve quality of life during their cancer treatment.